Most Popular Stories
- FDA approvals of 2011
- Will $1B cancer IP theft suit trigger tighter vigilance on researchers' work?
- Sanofi chief can't spark much enthusiasm for new MS drugs
- PhRMA's COPD pipeline report spotlights blockbuster hopefuls
- Merck steers top drug prospect to an NDA, analysts ponder R&D weakness
- Oracle announces new round of projects in IT, clinical trials
Free Newsletter
FierceBiomarkers provides biopharma executives and researchers with the latest news and trends on biomarkers. Sign up today to receive your FREE "insiders only" twice-monthly email briefing!
About | View Sample | Privacy
Top Tags
Biography for John Carroll
John D. Carroll is a biotech analyst with 32 years of prize-winning experience in journalism. Appointed editor of FierceBiotech in 2003, he has covered genomics, biotechnology, healthcare and other business topics for Managed Care, American Banker, Small Times, and Local Business.com, He has also contributed stories from Central America and Ireland to the Dallas Morning News and Time and wrote for the Houston Press and other leading publications. He spent six years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times. He enjoys hiking, traveling and spending time with his family. Carroll is based in Vermont and Texas and can be reached at john@fiercemarkets.com. Follow @JohnCFierce on Twitter.
Articles by John Carroll
- February 16, 2011
- February 16, 2011
- February 16, 2011
- February 16, 2011
- February 16, 2011
- February 16, 2011
- December 15, 2010
- December 15, 2010
- December 15, 2010
- December 15, 2010
- December 15, 2010
- December 15, 2010
- December 1, 2010
- December 1, 2010
- December 1, 2010
- December 1, 2010
- November 30, 2010
- November 17, 2010
- November 17, 2010
- November 17, 2010
- November 17, 2010
